36-Month Post Marketing Surveillance and Analysis of Menactra in 2-10 Year Olds.
Phase of Trial: Phase IV
Latest Information Update: 19 Feb 2015
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections; Meningococcal infections
- Focus Adverse reactions
- Sponsors Sanofi; sanofi pasteur
- 11 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 22 Apr 2013 Planned End Date changed from 1 Nov 2013 to 1 May 2014 as reported by ClinicalTrials.gov.
- 28 Mar 2013 Planned end date changed from 1 Nov 2012 to 1 Nov 2013 as reported by ClinicalTrials.gov.